Published 14 Jun 2016
FDA highlights Malvern’s innovative MDRS technology for Complex Generic drug product development
MDRS Technology Finally! After what has felt like one of the wettest and longest winters in memory here in the UK, we’re now heading into the long, mellow days of midsummer. But casting its miserable shadow over the barbecues, school…READ MORE >
Tags: ANDA, CDER, FDA, mometasone furoate